Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2024 年第 1 季持倉
持倉截至 2024/3/31，2024/5/14 申報。只含多頭部位，變化是跟 2023 年第 4 季比股數。
- 持股檔數
- 77
- 較 2023 年第 4 季 +4
- 總值
- $6.15 億
- 較 2023 年第 4 季 +$1.14 億 (+22.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | COM | 592,093 | $3,934 萬 | 6.4% | +55,000+10.2% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 837,387 | $3,605 萬 | 5.9% | +377,387+82.0% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 115,000 | $3,071 萬 | 5.0% | +15,000+15.0% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 470,000 | $2,200 萬 | 3.6% | +22,905+5.1% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 3,375,000 | $2,153 萬 | 3.5% | +1,824,592+117.7% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 510,000 | $2,140 萬 | 3.5% | +110,000+27.5% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 300,000 | $2,087 萬 | 3.4% | −40,000−11.8% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 470,000 | $2,027 萬 | 3.3% | +470,000 | 新進 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 2,642,519 | $2,024 萬 | 3.3% | +756,717+40.1% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $1,975 萬 | 3.2% | −500,000−26.3% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $1,830 萬 | 3.0% | – | – | – |
| KURAKura Oncology, Inc. | COM | 730,492 | $1,558 萬 | 2.5% | +538,957+281.4% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 410,000 | $1,555 萬 | 2.5% | −107,554−20.8% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 817,833 | $1,316 萬 | 2.1% | +254,009+45.1% | 加碼 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 82,143 | $1,285 萬 | 2.1% | +82,143 | 新進 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 300,000 | $1,268 萬 | 2.1% | −450,000−60.0% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 810,253 | $1,191 萬 | 1.9% | +120,141+17.4% | 加碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 845,606 | $1,190 萬 | 1.9% | −620,859−42.3% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 150,000 | $1,126 萬 | 1.8% | −25,000−14.3% | 減碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 139,758 | $1,115 萬 | 1.8% | +89,758+179.5% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 165,000 | $969.9 萬 | 1.6% | +90,000+120.0% | 加碼 | 歷史 |
| Alnylam Pharmaceuticals, Inc.02043QAB3 | NOTE 1.000% 9/1 | – | $944.9 萬 | 1.5% | – | 新進 | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 830,546 | $938.5 萬 | 1.5% | +34,817+4.4% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 285,000 | $920.8 萬 | 1.5% | −60,000−17.4% | 減碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,027,868 | $855.2 萬 | 1.4% | +477,868+86.9% | 加碼 | 歷史 |
| NARIInari Medical, Inc. | Stock | 175,000 | $839.6 萬 | 1.4% | +155,000+775.0% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 164,589 | $837.8 萬 | 1.4% | −63,688−27.9% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 2,500,000 | $825.0 萬 | 1.3% | +2,500,000 | 新進 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 225,000 | $792.0 萬 | 1.3% | +182,330+427.3% | 加碼 | 歷史 |
| Omeros Corp682143AG7 | NOTE 5.250% 2/1 | – | $763.2 萬 | 1.2% | – | – | – |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 286,200 | $676.9 萬 | 1.1% | +161,200+129.0% | 加碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 1,268,825 | $650.9 萬 | 1.1% | +1,268,825 | 新進 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM | 5,100,000 | $606.9 萬 | 1.0% | +5,100,000 | 新進 | 歷史 |
| ABSIAbsci Corp | COM | 1,025,000 | $582.2 萬 | 0.9% | +1,025,000 | 新進 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $578.5 萬 | 0.9% | – | – | – |
| SVRASavara Inc | COM | 1,150,000 | $572.7 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 80,000 | $560.9 萬 | 0.9% | −80,000−50.0% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 80,000 | $546.5 萬 | 0.9% | +55,000+220.0% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 500,000 | $527.0 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 550,339 | $519.5 萬 | 0.8% | +425,339+340.3% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 100,000 | $492.2 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 26,746 | $475.9 萬 | 0.8% | +1,746+7.0% | 加碼 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 1,000,000 | $448.0 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 258,588 | $440.6 萬 | 0.7% | −41,412−13.8% | 減碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 327,959 | $423.4 萬 | 0.7% | +327,959 | 新進 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 50,000 | $410.0 萬 | 0.7% | −250,000−83.3% | 減碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,600,000 | $408.0 萬 | 0.7% | +1,600,000 | 新進 | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 160,000 | $401.9 萬 | 0.7% | +110,000+220.0% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 75,000 | $376.7 萬 | 0.6% | +4,012+5.7% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 350,000 | $367.9 萬 | 0.6% | +150,000+75.0% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 50,000 | $346.0 萬 | 0.6% | +50,000 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 120,000 | $343.2 萬 | 0.6% | +120,000 | 新進 | 歷史 |
| NXTCNextCure, Inc. | COM | 1,359,037 | $303.1 萬 | 0.5% | +1,359,037 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 450,000 | $295.2 萬 | 0.5% | +384,000+581.8% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 100,000 | $289.3 萬 | 0.5% | +100,000 | 新進 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 250,000 | $258.8 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 110,000 | $231.8 萬 | 0.4% | +110,000 | 新進 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 202,599 | $223.7 萬 | 0.4% | +65,599+47.9% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 75,000 | $203.0 萬 | 0.3% | −281,384−79.0% | 減碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 286,585 | $176.8 萬 | 0.3% | +286,585 | 新進 | 歷史 |
| BSXBoston Scientific Corp | Stock | 25,000 | $171.2 萬 | 0.3% | +25,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 1,761,778 | $158.8 萬 | 0.3% | +1,761,778 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 50,000 | $154.6 萬 | 0.3% | −30,000−37.5% | 減碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 133,500 | $150.5 萬 | 0.2% | +133,500 | 新進 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 150,274 | $119.3 萬 | 0.2% | −150,000−50.0% | 減碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 450,009 | $115.7 萬 | 0.2% | +450,009 | 新進 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 50,000 | $114.5 萬 | 0.2% | −18,081−26.6% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 125,000 | $96.4 萬 | 0.2% | +125,000 | 新進 | 歷史 |
| TECXTectonic Therapeutic, Inc. | COM | 700,000 | $89.6 萬 | 0.1% | +200,000+40.0% | 加碼 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM | 265,958 | $50.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 187,204 | $48.7 萬 | 0.1% | 00.0% | 不變 | – |
| QTTBQ32 Bio Inc. | COM | 27,777 | $47.3 萬 | 0.1% | +27,777 | 新進 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 328,817 | $45.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PASGPassage BIO, Inc. | COM | 264,266 | $35.7 萬 | 0.1% | +264,266 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 10,000 | $21.8 萬 | <0.1% | +10,000 | 新進 | 歷史 |
| Cassava Sciences Inc14817C115 | *W EXP 11/15/202 | 24,200 | $9.75 萬 | <0.1% | +24,200 | 新進 | – |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $2.24 萬 | <0.1% | 00.0% | 不變 | – |
選擇權（17 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $6,642 萬 | – |
| MRNAModerna, Inc. | Stock | $4,262 萬 | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $2,335 萬 |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | – | $896.7 萬 |
| BBIOBridgeBio Pharma, Inc. | COM | – | $773.0 萬 |
| GRTSGritstone bio, Inc. | COM | $614.4 萬 | – |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | – | $597.8 萬 |
| RAPTRAPT Therapeutics, Inc. | COM | $518.2 萬 | $53.9 萬 |
| GHGuardant Health, Inc. | COM | – | $515.8 萬 |
| IMVTImmunovant, Inc. | COM | – | $466.6 萬 |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | – | $443.0 萬 |
| IBRXImmunityBio, Inc. | COM | $316.5 萬 | – |
| FULCFulcrum Therapeutics, Inc. | COM | – | $259.6 萬 |
| ESTAEstablishment Labs Holdings Inc. | COM | – | $254.5 萬 |
| AKROAkero Therapeutics, Inc. | COM | – | $189.4 萬 |
| ANVSAnnovis Bio, Inc. | COM | $86.8 萬 | – |
| CBIOCrescent Biopharma, Inc. | COM | $42.7 萬 | – |
2023 年第 4 季之後清倉（21 檔）
2023 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 4 季股數 | 2023 年第 4 季市值 | 2023 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 1,404,608 | $4,165 萬 | 8.3% | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 1,090,441 | $2,576 萬 | 5.1% | 歷史 |
| LIANYLianBio | SPONSORED ADS | 3,779,694 | $1,690 萬 | 3.4% | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 100,049 | $587.8 萬 | 1.2% | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 300,000 | $419.4 萬 | 0.8% | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 60,000 | $404.1 萬 | 0.8% | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 300,000 | $330.3 萬 | 0.7% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 7,500 | $285.3 萬 | 0.6% | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 109,900 | $254.0 萬 | 0.5% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $251.9 萬 | 0.5% | 歷史 |
| PENPenumbra Inc | COM | 7,500 | $188.7 萬 | 0.4% | 歷史 |
| ADCTADC Therapeutics SA | SHS | 1,013,540 | $168.2 萬 | 0.3% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 125,969 | $154.3 萬 | 0.3% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 10,000 | $131.8 萬 | 0.3% | 歷史 |
| ALLOAllogene Therapeutics, Inc. | COM | 400,000 | $128.4 萬 | 0.3% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 50,000 | $108.9 萬 | 0.2% | 歷史 |
| BHVNBiohaven Ltd. | COM | 20,866 | $89.3 萬 | 0.2% | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 202,349 | $87.6 萬 | 0.2% | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $37.8 萬 | 0.1% | 歷史 |
| IFRXInflaRx N.V. | COM | 200,097 | $32.6 萬 | 0.1% | 歷史 |
| ARAVAravive, Inc. | COM | 346,511 | $4.29 萬 | <0.1% | 歷史 |